DEFA14A: Ingevity Files Definitive Proxy Statement, Urges Stockholders to Vote for Company's Director Nominees Amid Proxy Fight

Ingevity Corporation has filed its definitive proxy statement and is urging stockholders to vote for its nine director nominees on the WHITE proxy card at the upcoming Annual Meeting on April 30, 2025, amidst a proxy fight with Vision One.

Summary

• Ingevity Corporation filed its definitive proxy statement on March 20, 2025, for its Annual Meeting of Stockholders to be held on April 30, 2025.
• The company's Board of Directors recommends stockholders vote for Ingevity's nine director nominees on the WHITE proxy card.
• Ingevity has undertaken significant changes to its business in response to external market challenges, including rationalizing its physical footprint, diversifying raw material streams, and exiting lower-margin markets.
• In 2024, Ingevity reported revenues of over $1.4 billion, adjusted EBITDA of over $362 million, cost savings of $84 million, and free cash flow of $51 million.
• The company projects 10-14% adjusted EBITDA growth and free cash flow approximately 4-5x the 2024 level in 2025.
• Ingevity appointed David H. Li as its next President and CEO, effective April 7, 2025, and Michael Shukov as Senior Vice President and President of Advanced Polymer Technologies.
• Vision One, a stockholder, has nominated two directors for election to the Ingevity Board, which the Board opposes.
• Ingevity is soliciting votes from stockholders to support its director nominees and encourages stockholders to discard any gold proxy card received from Vision One.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook for Ingevity, highlighting strong financial results, cost savings, and the appointment of a new CEO; however, the proxy fight with Vision One introduces some uncertainty.

Positives

• Ingevity delivered strong 2024 financial results, including revenues of over $1.4 billion and adjusted EBITDA of over $362 million.
• The company exceeded its cost savings target for 2024, achieving $84 million in savings.
• Free cash flow in 2024 was well above prior guidance at $51 million.
• Ingevity projects significant adjusted EBITDA growth and free cash flow improvement in 2025.
• The company has appointed a new President and CEO with a strong track record of shareholder value creation.
• Ingevity's stock has outperformed the S&P 400 Chemicals Index since the announcement of the CEO search.

Negatives

• Ingevity faced challenges due to unprecedented increases in crude tall oil (CTO) costs and demand softness in primary end-markets beginning in 2022.
• The company is engaged in a proxy fight with Vision One, which is seeking to elect its own director nominees.

Risks

• The proxy fight with Vision One could be a distraction for management and divert resources.
• The company acknowledges that actual results could differ materially from forward-looking statements due to various factors, including economic conditions, competition, and raw material costs.
• The company is exposed to risks related to international sales and operations, adverse conditions in the automotive market, and supply chain disruptions.

Future Outlook

Ingevity expects further progress in 2025, projecting 10-14% adjusted EBITDA growth, free cash flow that is approximately 4-5x the 2024 level, additional cost savings of $10-25 million and a reduction of its net debt ratio to less than 2.8x.

Management Comments

• The Ingevity Board of Directors and management team have undertaken a series of fundamental changes to the business in response to external market challenges.
• Luis Fernandez-Moreno, interim CEO, has continued to drive execution of the business, announced a comprehensive portfolio review and focused on recruiting top management talent.
• The Board concluded that appointing one of Vision One's insiders would not be in the best interests of all Ingevity stockholders.

Industry Context

Ingevity operates in the specialty chemicals industry and faces competition from other companies in the sector; the company's performance is affected by factors such as raw material costs, demand in end-markets, and global economic conditions.

Comparison to Industry Standards

• David H. Li, the new CEO, previously delivered ~300% total shareholder returns at CMC Materials as compared to ~78% for the S&P 400.
• Under Mr. Li's leadership, CMC Materials achieved ~16% cumulative annual revenue growth and ~14% cumulative annual operating profit growth.
• Mr. Li led the $6.5 billion sale of CMC Materials to Entegris at a 35% premium.

Management Changes

Stakeholder Impact

• Shareholders are being asked to vote on director nominees.
• Employees are being asked to remain focused on their day-to-day responsibilities during the proxy solicitation period.
• Customers are expected to continue receiving products and services without disruption.

Next Steps

• Ingevity will continue to engage with stockholders and provide updates on its progress.
• The company will solicit votes from stockholders for its director nominees at the Annual Meeting on April 30, 2025.

Key Dates

Keywords

proxy fight, director nominees, annual meeting, stockholders, EBITDA, free cash flow, CEO, Ingevity, Vision One